WTZ Cancer Center Director Univ. Prof. Dr. med. Angelika Eggert ...

2. Coordinator
Kurt Werner Schmid, MD, MRCPath,
Professor of Pathology, Director,
Institute of Pathology and Neuropathology
6. Selected publications 2005 – 2008
Lehnerdt GF, Franz P, Zaqoul A, Schmitz KJ, Grehl S, Lang S, Schmid KW Siffert W, Jahnke K,
Frey UH. Overall and relapse-free survival in oropharyngeal and hypopharyngeal squamous cell
carcinoma are associated with genotypes of T393C polymorphism of the GNAS1 gene.
Clin Cancer Res. 2008; 14: 1753-1758. IF 6.2
Schmitz KJ, Wohlschlaeger J, Lang H, Sotiropoulos, GC, Malago M, Steveling K, Reis H,
Cicinnati VR, Schmid KW, Baba HA. Activation of the ERK and AKT signalling pathway predicts
poor prognosis in hepatocellular carcinoma and ERK activation in cancer tissue is associated
with hepatitis C virus infection
J Hepatol. 2008; 48: 83-90. IF 6.1
Bachmann HS, Otterbach F, Callies R, Nuckel H, Bau M, Schmid KW, Siffert W, Kimmig R. The
AA Genotype of the Regulatory BCL2 Promoter Polymorphism (938>A) Is Associated with a
Favorable Outcome in Lymph Node Negative Invasive Breast Cancer Patients.
Clin Cancer Res. 2007; 13:5790-7. IF 6.2
Grabellus F, Ebeling P, Worm K, Sheu SY, Antoch G, Frilling A, Schmid KW. Double resistance
to imatinib and AMG 706 caused by multiple acquired KIT exon 17 mutations in a gastrointestinal
stromal tumour.
Gut. 2007; 56:1025-6. IF 9.0
Schmitz KJ, Lang H, Frey UH, Sotiropulos GC, Wohlschlaeger J, Reis H, Takeda A, Siffert W,
Schmid KW, Baba HA. The GNAS1 T393C polymorphism is associated with the clinical course
In patients with intrahepatic cholangiocarcinoma.
Neoplasia 2007; 9:159-65. IF 4.9
Sheu S-Y, Handke S, Bröcker-Preuss M, Görges R, Frey UH, Ensinger C, Öfner D, Farid NR,
Siffert W, Schmid KW. The C allele of the GNB3 C825T polymorphism of the G protein β3-
subunit is associated with an increased risk for the development of oncocytic thyroid tumours.
J Pathol. 2007; 211:60-66. IF 5.8
Frey UH, Lümmen G, Jäger T, Jöckel K-H, Schmid KW, Rübben H, Siffert W, Eisenhardt A.
The GNAS1 T393C polymorphism predicts the clinical outcome in patients with clear cell renal
cell carcinoma.
Clin Cancer Res. 2006; 12:759-63 IF 5.6
Sheu S-Y, Görges R, Ensinger C, Öfner D, Farid NR, Siffert W, Schmid KW. Different genotype
distribution of the GNB3 C825T polymorphism of the G protein ß3 subunit in adenomas and
differentiated thyroid carcinomas of follicular cell origin.
J Pathol 2005; 207:430-435 IF 5.3
Gashaw I, Grummer R, Klein-Hitpass L, Dushaj O, Bergmann M, Brehm R, Grobholz R,
Kliesch S, Neuvians TP, Schmid KW, Ostau CV, Winterhager E. Gene signatures of testicular
seminoma with emphasis on expression of ets variant gene 4.
Cell Mol Life Sci. 2005; 62:2359-68. IF 4.8
Frey UH, Alakus H, Wohlschlaeger J, Schmitz KJ, Winde G, van Calker HG, Jaeckel KH, Siffert
W, Schmid KW. GNAS1 T393C polymorphism and survival in patients with sporadic colorectal
cancer.
Clin Cancer Res. 2005; 15:5071-7. IF 5.6